Patient Guide: A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 259 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05100862
Status: 🟢 Enrolling Now
Condition: Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 259 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Fresno, California
  • Los Alamitos, California
  • Los Angeles, California
  • • And 256 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily